China Pharma Holdings (CPHI)
(Delayed Data from AMEX)
$0.36 USD
+0.03 (8.87%)
Updated May 20, 2024 04:00 PM ET
After-Market: $0.36 0.00 (0.84%) 4:34 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
China Pharma Holdings, Inc. [CPHI]
Reports for Purchase
Showing records 1 - 20 ( 33 total )
Company: China Pharma Holdings, Inc.
Industry: Medical - Generic Drugs
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: China Pharma Holdings, Inc.
Industry: Medical - Generic Drugs
Company: China Pharma Holdings, Inc.
Industry: Medical - Generic Drugs
Company: China Pharma Holdings, Inc.
Industry: Medical - Generic Drugs
ValuEngine Detailed Valuation Report for CPHI
Provider: VALUENGINE, INC
Company: China Pharma Holdings, Inc.
Industry: Medical - Generic Drugs
The Chinese Pharmaceutical Industry: Fortnightly Update
Provider: RODMAN & RENSHAW, CO.
Analyst: PIROS E
Company: China Pharma Holdings, Inc.
Industry: Medical - Generic Drugs
The Chinese Pharmaceutical Industry: Fortnightly Update
Provider: RODMAN & RENSHAW, CO.
Analyst: PIROS E
Company: China Pharma Holdings, Inc.
Industry: Medical - Generic Drugs
The Chinese Pharmaceutical Industry: Fortnightly Update
Provider: RODMAN & RENSHAW, CO.
Analyst: PIROS E
Company: China Pharma Holdings, Inc.
Industry: Medical - Generic Drugs
The Chinese Pharmaceutical Industry: Fortnightly Update
Provider: RODMAN & RENSHAW, CO.
Analyst: PIROS E
Company: China Pharma Holdings, Inc.
Industry: Medical - Generic Drugs
The Chinese Pharmaceutical Industry: Fortnightly Update
Provider: RODMAN & RENSHAW, CO.
Analyst: PIROS E
Company: China Pharma Holdings, Inc.
Industry: Medical - Generic Drugs
Company: China Pharma Holdings, Inc.
Industry: Medical - Generic Drugs
Company: China Pharma Holdings, Inc.
Industry: Medical - Generic Drugs
Generic Crestor Clinical Trials Completed - Potential Blockbuster
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: China Pharma Holdings, Inc.
Industry: Medical - Generic Drugs
The Chinese Pharmaceutical Industry: Fortnightly Update
Provider: RODMAN & RENSHAW, CO.
Analyst: PIROS E
Company: China Pharma Holdings, Inc.
Industry: Medical - Generic Drugs
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: China Pharma Holdings, Inc.
Industry: Medical - Generic Drugs
High-Tech Enterprise Status Provides Favorable Tax Rate - Benefits to the Bottom Line
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: China Pharma Holdings, Inc.
Industry: Medical - Generic Drugs
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: China Pharma Holdings, Inc.
Industry: Medical - Generic Drugs
3Q10 UPDATE - IN LINE QUARTER - PIPELINE TO DRIVE REVENUE INFLECTION POINT
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: China Pharma Holdings, Inc.
Industry: Medical - Generic Drugs
The Chinese Pharmaceutical Industry: Fortnightly Update
Provider: RODMAN & RENSHAW, CO.
Analyst: PIROS E
Company: China Pharma Holdings, Inc.
Industry: Medical - Generic Drugs
The Chinese Pharmaceutical Industry: Fortnightly Update
Provider: RODMAN & RENSHAW, CO.
Analyst: PIROS E
Company: China Pharma Holdings, Inc.
Industry: Medical - Generic Drugs
The Chinese Pharmaceutical Industry: Fortnightly Update
Provider: RODMAN & RENSHAW, CO.
Analyst: PIROS E